Anavex Life Sciences Corp (AVXL)

[boi568]

I really, really like your creative suggestion to see if it is possible to seek FDA approval for GABA and glutamate normalization. Whether or not this requires the FDA to act outside the box, it can provide a quickly demonstrable path for 2-73 across multiple indications. GABA and glutamate are unlikely to be the whole ball game for Sigma 1 receptor related diseases, or even all diseases that can benefit from 2-73, but so what? We can start with Rett and Parkinson's and go on from there. Later we can apply on the current schedule for Alzheimer's.

It may take a while for medicine to catch up to this approach but it will allow quick results where applied. I just don't know how FDA regulations and guidances interact with your idea.

Hope Anavex sees your post.